Anemia of chronic disease.
- G. Weiss, L. Goodnough
- MedicineNew England Journal of Medicine
- 10 March 2005
Advances in knowledge of the causes and management of the anemia of chronic disease are discussed.
Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.
- X. Zheng, R. Kaufman, L. Goodnough, J. Sadler
- Medicine, BiologyBlood
- 1 June 2004
Assays of ADAMTS13 activity and inhibitors in addition to the clinical categories (idiopathic TTP and nonidiopathy TTP) are predictive of outcome and may be useful to tailor patient treatment.
2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.
- V. Ferraris, Jeremiah R. Brown, Kenneth G. Shann
- MedicineAnnals of Thoracic Surgery
- 1 March 2011
Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines
- L. Goodnough, A. Maniatis, M. Szpalski
- MedicineBritish Journal of Anaesthesia
- 1 January 2011
It is suggested that erythropoiesis-stimulating agents be used for anaemic patients in whom nutritional deficiencies have been ruled out, corrected, or both and that nutritional deficiencies be treated.
Transfusion medicine. First of two parts--blood transfusion.
- L. Goodnough, M. Brecher, M. Kanter, J. AuBuchon
- MedicineNew England Journal of Medicine
- 11 February 1999
This review summarizes recent developments in transfusion medicine that have affected the field and the identification of patients most likely to benefit from blood conservation.
Anemia of inflammation.
- G. Weiss, T. Ganz, L. Goodnough
- Medicine, BiologyBlood
- 3 January 2019
Based on experience with anemia treatment in chronic kidney disease, critical illness, and cancer, finding the appropriate indications for the specific treatment of AI will require improved understanding and a balanced consideration of the contribution of anemia to each patient's morbidity and the impact of anemic treatment on the patient's prognosis in a variety of disease settings.
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.
- J. McCullough, D. Vesole, M. Conlan
- Medicine, BiologyBlood
- 1 September 2004
The incidence of grade 2 bleeding was equivalent for PCT and conventional platelets, although posttransfusion platelet count increments and days to next transfusion were decreased for P CT compared with conventional platelet transfusions.
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.
- C. Jacobs, G. Lyman, L. Schacter
- MedicineJournal of Clinical Oncology
- 1 February 1992
Although the response rate to the combination of CP plus 5-FU was superior to that achieved with single agents, survival did not improve and patients with better PS and poorly differentiated tumors had superior survival.
Transfusion medicine: looking to the future
- L. Goodnough, A. Shander, M. Brecher
- MedicineThe Lancet
- 11 January 2003
Detection, evaluation, and management of iron-restricted erythropoiesis.
- L. Goodnough, E. Nemeth, T. Ganz
- MedicineBlood
- 2 December 2010
This review summarizes recent advances regarding the detection, evaluation, and management of iron-restricted erythropoiesis.
...
...